Health
Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities – News-Medical.Net
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications…
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
In a review article in Trends in Cancer, the team presented evidence that immunotherapies such as immune checkpoint inhibitors (which enable T cells to attack and kill cancer…
-
Noosa News23 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General24 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General17 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General16 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues